MINUTES OF PROCEEDINGS

WEDNESDAY, DECEMBER 6, 1995
(Meeting No. 19)

[Text]

The Sub-Committee on HIV/AIDS of the Standing Committee on Health met in a televised session at 3:45 o'clock p.m. this day, in Room 237-C, Centre Block, the Chairman, Bernard Patry, presiding.

Members of the Sub-Committee present: Hedy Fry, Sharon Hayes, Ovid L. Jackson, Réal Ménard, Bernard Patry and Rose-Marie Ur.

Other Member present: Sue Barnes.

In attendance: From the Research Branch of the Library of Parliament: Odette Madore and Bill Murray, Research Officers.

Witnesses: From COCQ-sida: Lise Pinault, Director General. From AIDS Coalition of Nova Scotia: James Shedden, Men's Project Coordinator. As individuals: Susan Conrad; Ahmed Hassan. From Burlington Breast Cancer Support Group: Pat Kelly, Member. From Canadian Breast Cancer Network: Sharon Batt, Member. From the Canadian Haemophilia Society: Lorraine Parsons, Member, Ottawa Chapter. As individuals: Dr. Ken Logue; Dr. Doug McFadden, From the Ottawa General Hospital: Diane Fillion, Nursing Co-ordinator, AIDS Clinic. As individual: Dr. Christos Tsoukas. From Wellsley Health Centre: Mary Grondin, Nursing Co-ordinator. From the Pharmaceutical Manufacturers Association: Dr. Sophia Fourie, Vice-President, Medical & Regulatory Affairs, Pharmacea and Upjohn, Inc.; Dr. Michael D. Levy, Vice-President, Medical Sciences, Glaxo Wellcome; William D. Milligan, Vice-President, Biomed Business Unit, Hoffmann La Roche.

Pursuant to Standing Order 108(2), the Sub-Committee proceeded to a National Roundtable on Compassionate Access to Experimental Drugs.

Lise Pinault and James Shedden each made opening statements.

At 4:10 o'clock p.m., the sitting was suspended.

At 4:30 o'clock p.m., the sitting resumed.

Susan Conrad, Ahmed Hassan, Pat Kelly, Sharon Batt and Lorraine Parsons each made opening statements and, together with Lise Pinault and James Shedden, answered questions.

Dr. Ken Logue, Dr. Doug MacFadden, Diane Fillion, Dr. Christos Tsoukas and Mary Grondin each made opening statements and answered questions.

Dr. Sophia Fourie, Dr. Michael Levy and William Milligan each made opening statements and answered questions.

At 8:00 o'clock p.m., the Sub-Committee adjourned to the call of the Chair.

THURSDAY, DECEMBER 7, 1995
(Meeting No. 20)

[Text]

The Sub-Committee on HIV/AIDS of the Standing Committee on Health met in a televised session at 9:15 o'clock a.m. this day, in Room 253-D, Centre Block, the Chairman, Bernard Patry, presiding.

Members of the Sub-Committee present: Hedy Fry, Ovid L. Jackson, Réal Ménard, Bernard Patry and Rose-Marie Ur.

In attendance: From the Research Branch of the Library of Parliament: Odette Madore and Bill Murray, Research Officers.

Witnesses: From the Department of Health: Beth Pieterson, Chief, Submission and Information Policy Division. Dr. Tomasz Uscinowicz, Manager, Clinical Trials and Special Access Program, Drugs Directorate. Dr. Jacques Bouchard, Acting Chief, AIDS and Viral Diseases Division, Bureau of Human Prescription Drugs. From COCQ-sida: Lise Pinault, Coordinator. From the Nova Scotia Aids Coalition: James Shedden, Men's Project Coordinator. From the Ottawa General Hospital: Dr. Bill Cameron, Clinical Trials Network. From the Canadian Association for HIV Research: Dr. Mark Wainberg. From the Community AIDS Treatment Information Exchange: Dierdre MacLean, Community Liaison Coordinator. From the Pharmaceutical Manufacturers Association of Canada: Dr. Sophia Fourie, Vice-President, Medical & Regulatory Affairs, Pharmacea and Upjohn, Inc.; Dr. Michael Levy, Vice-President, Medical Sciences, Glaxo Wellcome; William Milligan, Vice-President, Biomedical Business Unit, Hoffmann La Roche. As individuals: Dr. Doug MacFadden; Dr. Ken Logue.

Pursuant to Standing Order 108(2), the Committee resumed consideration of its National Roundtable on Compassionate Access to Experimental Drugs (See Minutes of Proceedings, dated Wednesday, December 6, 1995, Issue No. 9).

Beth Pieterson, Dr. Tomasz Uscinowciz and Dr. Bouchard, James Shedden, Dr. Bill Cameron, Dr. Mark Wainberg, Dr. Ken Logue, Dierdre Maclean, Dr. Michael Levy and Dr. Sophia Fourie each made opening statements and together with Lise Pinault and Dr. Doug MacFadden answered questions and participated in a roundtable discussion with members of the Sub-Committee.

At 12:15 o'clock p.m., the Sub-Committee adjourned to the call of the Chair.

WEDNESDAY, DECEMBER 13, 1995
(Meeting No. 21)

[Text]

The Sub-Committee on HIV/AIDS of the Standing Committee on Health met in televised session at 3:30 o'clock p.m. this day, in Room 308, West Block, the Chairman, Bernard Patry, presiding.

Members of the Sub-Committee present: Hedy Fry, Sharon Hayes, Ovid L. Jackson, Réal Ménard, Bernard Patry, Svend Robinson and Rose-Marie Ur.

In attendance: From the Research Branch of the Library of Parliament: Odette Madore and Bill Murray, Research Officers.

Witnesses: From Justice Canada: Mario Simard, Senior Legal Counsel, Legal Services, Health Canada. From the Pharmaceutical Manufacturers' Association of Canada: Dr. Sophia Fourie, Vice-President, Medical & Regulatory Affairs, Pharmacea and Upjohn, Inc.. Dr. Michael Levy, Vice-President, Medical Sciences, Glaxo Wellcome. From the McGill Centre for Medecine, Ethics and the Law: Trudo Lemmens. From B.C. People with AIDS: Arn Schilder, Vice-Chair. From the Medical Research Council of Canada: Dr. Michel Denis, Scientific Officer. From the National Council on Bioethics in Human Research: Derek Jones, Director. From the Canadian Cancer Society: Dr. Neill Iscoe, President, Ontario Chapter. From the Faculty of Medecine, Dalhousie University: Dr. John Ruedy, Dean. From the Canadian HIV Trials Network: Dr. Don Zarowny. As Individuals: John Dixon; Dr. Sharon Walmsley.

Pursuant to Standing Order 108(2), the Committee resumed consideration of its National Roundtable on Compassionate Access to Experimental Drugs (See Minutes of Proceedings, dated Wednesday, December 6, 1995, Issue No. 9).

Mario Simard, Dr. Sophia Fourie, Dr. Michael Levy and Trudo Lemmens each made opening statements and answered questions.

Arn Schilder, Dr. Michel Denis, Derek Jones, Dr. Neill Iscoe, Dr. John Ruedy, and Dr. Don Zarowny each made opening statements and answered questions.

At 5:15 o'clock p.m., the sitting was suspended and the Chairman left the Chair.

At 6:00 o'clock p.m., the sitting resumed, the Vice-Chair, Réal Ménard, presiding.

Dr. Sharon Walmsley and John Dixon each made opening statements and answered questions.

All participants then engaged in a Roundtable discussion together with Members of the Sub-Committee.

At 7:00 o'clock p.m., the Sub-Committee adjourned to the call of the Chair.

THURSDAY, DECEMBER 14, 1995
(Meeting No. 22)

[Text]

The Sub-Committee on HIV/AIDS of the Standing Committee on Health met in a televised session at 9:15 o'clock a.m. this day, in Room 237-C, Centre Block, the Chair, Bernard Patry, presiding.

Members of the Sub-Committee present: Sharon Hayes, Ovid L. Jackson, Réal Ménard, Bernard Patry and Rose-Marie Ur.

Acting Member present: Rex Crawford for Harold Culbert.

In attendance: From the Research Branch of the Library of Parliament: Odette Madore and Bill Murray, Research Officers.

Witnesses: From the Pharmaceutical Manufacturers' Association of Canada: Dr. Sophia Fourie, Vice-President, Medical & Regulatory Affairs, Pharmacea and Upjohn, Inc. Dr. Michael Levy, Vice-President, Medical Sciences, Glaxo Wellcome. Dr. William Milligan, Vice-President, Biomed Business Unit, Pharmaceutical Division, Hoffmann-La Roche Limited. From B.C. People with AIDS: Arn Schilder, Vice-Chair. From Access to Effective Cancer Care in Ontario: Carol Harkness, Member. From the Canadian Life and Health Insurance Association: Charles Black, Senior Advisor, Insurance Operations. Gerry Byrne, Liberty Health, Member Company. From the Canadian HIV Trials Network: Dr. Michael O'Shaughnessy. From the Ministry of Health, Government of Ontario: Lance Payne, Drug Programs. From Health Canada: Beth Pieterson, Chief, Submission and Information Policy Division; Dr. Jacques Bouchard, Acting Chief, AIDS and Viral Diseases Division, Bureau of Human Prescription Drugs. As Individuals: Dr. Robert Voigt; Dr. Sharon Walmsley.

Pursuant to Standing Order 108(2), the Committee resumed consideration of its National Roundtable on Compassionate Access to Experimental Drugs (See Minutes of Proceedings, dated Wednesday, December 6, 1995, Issue No. 9).

Dr. Sophia Fourie, Arn Schilder, Carol Harkness, Charles Black, Gerry Byrne, Dr. Michael O'Shaughnessy, Dr. Robert Voigt, Dr. Sharon Walmsley and Lance Payne each made opening statements and together with Beth Pieterson and Dr. Jacques Bouchard answered questions.

At 11:05 o'clock a.m., the sitting was suspended.

At 11:26 o'clock a.m., the sitting resumed.

All witnesses, including Dr. Michael Levy and William Milligan, then participated in a Roundtable discussion together with Members of the Sub-Committee.

It was agreed,--That the Clerk and the Research Staff undertake research and prepare a draft workplan for a Roundtable session on directions and needs in HIV research to be presented to the Sub-Committee for its consideration when the House reconvenes in 1996.

At 11:55 o'clock a.m., the Sub-Committee adjourned to the call of the Chair.

Nancy Hall

Clerk of the Sub-Committee